COVID vaccines
Vietnam homegrown COVID vaccine heads for full approval by year-end
Doses enter Phase 3 trials, but Hanoi could approve emergency use as cases climb
Health Care & Pharma
Companies
Malaysia's Top Glove Q3 earnings dented by US import ban
But net profit and sales surge from same period last year as pandemic worsened
Interview
Eisai CEO sets sights on Asia with Alzheimer's drug approved in US
Haruo Naito sees 'enormous' market in China, Japan and elsewhere
Pharmaceuticals
Alzheimer's 'grand slam' for Biogen and Eisai: five things to know
Treatment for dementia still faces financial and regulatory hurdles
Pharmaceuticals
Biogen and Eisai's dementia drug tie-up pays off with US approval
New treatment holds promise for Alzheimer's patients but obstacles remain
Pharmaceuticals
FDA approves Biogen and Eisai's much-debated Alzheimer's drug
Decision likely to spark disagreements among physicians and patient groups
COVID vaccines
Israel sees probable link between Pfizer jab and myocarditis
Small number of mainly young men experience heart inflammation, ministry says
Markets
'Three-child' policy switch lifts Chinese baby and health stocks
Analysts urge Beijing to reduce child-rearing costs to support more births
DealStreetAsia
Indian health insurance startup raises $16m led by Tiger Global
Plum aims to use new funds to reach 10 million customers by 2025
Interview
UK health secretary to urge flu shot model for COVID-19 at G-7
Nations should seek shared trial standards to speed variant vaccines, Hancock says
